ResoTher Pharma
PrivateLast Round
Reverse Merger
Mar 30, 2026
Est. Valuation
$36.58M
Total Funding Raised
$2.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ResoTher Pharma is a biotechnology company that develops peptide-based therapeutics intended for inflammation resolution in cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResoTher Pharma Comparables
Compare ResoTher Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serpin Pharma | 78% | |
| Novo Nordisk | 73% | |
| Epoqe Pharma | 73% | |
ResoTher Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Mar 30, 2026 | ||||
| Grant | Nov 7, 2023 | ||||
| Private Placement | May 4, 2021 | ||||
| Private Placement | Nov 1, 2019 | ||||
| Seed | Nov 17, 2017 |
Key People
Founding team and executive leadership
ResoTher Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Axilium Capital | Private Placement |
| Innovation Fund Denmark | Private Placement |
| European Innovation Council Fund | Grant |
| North Finance A/S | Private Placement |
| European Commission | Private Placement |
| Capnova | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 47% MoM.
- Apr 6, 2026
Monthly visitors grew 1050% MoM, from 140 to 1.6K.
ResoTher Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ResoTher Pharma's valuation, stock price, and market status.